What is the recommended approach to diagnosing acute coronary syndrome (ACS) in a patient presenting with chest pain?

Diagnosing Acute Coronary Syndrome

The diagnosis of ACS requires an immediate 12-lead ECG (within 10 minutes of presentation) to differentiate STEMI from non-ST-elevation ACS, combined with high-sensitivity cardiac troponin measurement using either a 0/1-hour or 0/2-hour algorithm, plus assessment of ischemic symptoms. 1

Initial Diagnostic Algorithm

Step 1: Immediate ECG (≤10 minutes)

The ECG immediately stratifies patients into two critical pathways 2, 1, 3:

• Persistent ST-elevation (>20 min): STEMI pathway → immediate reperfusion therapy
• No persistent ST-elevation: NSTE-ACS pathway → proceed to troponin-based algorithm

ECG findings in NSTE-ACS may show transient ST-elevation, ST-depression, T-wave inversions, flat T-waves, pseudo-normalization, or be completely normal 1.

Step 2: High-Sensitivity Troponin Protocol

Use validated rapid protocols based on your institution's assay 1, 2:

0/1-hour algorithm (preferred):

• Measure hs-cTn at presentation (0 hour) and 1 hour
• Values above 99th percentile with dynamic change (rise or fall) = rule-in for MI
• Values below limit of detection at both timepoints = rule-out
• If inconclusive, repeat at 3-6 hours 2, 4

0/2-hour algorithm (alternative):

• Same principle with 2-hour interval instead of 1-hour 1

Conventional troponin (if hs-cTn unavailable):

• Repeat at 3-6 hours after initial sample 4

Step 3: Clinical Criteria for MI Diagnosis

MI requires BOTH elevated troponin (>99th percentile with dynamic change) AND at least one of the following 2, 1:

1. Symptoms of myocardial ischemia
2. New ischemic ECG changes (ST-segment or T-wave abnormalities, new LBBB)
3. Development of pathological Q waves
4. Imaging evidence of new loss of viable myocardium or regional wall motion abnormality
5. Intracoronary thrombus on angiography

Risk Stratification for Immediate Management

Very High-Risk (immediate invasive strategy <2 hours) 2:

• Hemodynamic instability or cardiogenic shock
• Recurrent/ongoing chest pain refractory to medical treatment
• Life-threatening arrhythmias or cardiac arrest
• Mechanical complications of MI
• Acute heart failure with refractory angina or ST deviation
• Recurrent dynamic ST/T-wave changes, especially intermittent ST-elevation

High-Risk (early invasive strategy <24 hours) 2:

• Rise/fall in troponin compatible with MI
• Dynamic ST/T-wave changes (symptomatic or silent)
• GRACE score >140

Intermediate-Risk (invasive strategy <72 hours) 2:

• Diabetes mellitus
• Renal insufficiency (eGFR <60 mL/min/1.73 m²)
• LVEF <40% or heart failure
• Early post-infarction angina
• Recent PCI or prior CABG
• GRACE score 109-140

Adjunctive Diagnostic Tools

Echocardiography is recommended to evaluate regional/global LV function and exclude differential diagnoses 2.

Risk scores enhance diagnostic accuracy 5:

• HEART score 7-10: LR 13 for ACS (high-risk)
• HEART score 0-3: LR 0.20 for ACS (effectively rules out)
• TIMI score 5-7: LR 6.8 for ACS (high-risk)
• TIMI score 0-1: LR 0.31 for ACS (low-risk)

Critical Pitfalls to Avoid

1. Don't rely on clinical findings alone: Prior abnormal stress test (LR 3.1), peripheral arterial disease (LR 2.7), and bilateral arm radiation (LR 2.6) increase probability, but history and physical examination cannot confirm or exclude ACS without troponin and ECG 5, 3

2. Atypical presentations are common: 40% of men and 48% of women present without chest pain, instead having dyspnea or other nonspecific symptoms 3

3. Normal initial troponin doesn't exclude ACS: Serial measurements are essential unless using validated rapid rule-out algorithms 2, 4

4. 5-20% of ACS patients have non-obstructive CAD on angiography, particularly women 2, 1

5. ECG may be completely normal in NSTE-ACS—approximately 41% show neither ST-depression nor T-wave inversion 3

Comparison with Newer Modalities

While coronary CTA shows higher diagnostic accuracy than hs-troponin alone (AUC 0.96 vs 0.86) 6, the guideline-recommended approach prioritizes the ECG/troponin algorithm because it's faster, more widely available, and directly guides immediate treatment decisions 1. CTA may be considered for low-to-intermediate risk patients when troponin results are indeterminate 7.